Experimental evaluation myocardial protective effect prostacyclin analog adjunct solution stable prostacyclin analog myocardial protective effect global ischemia use cardioplegia canine hearts minutes warm degrees global ischemia arrest crystalloid cardioplegia Prostaglandin analog different ways preadministration body weight minute ischemia minutes group component cardioplegic solution group II post-administration body weight minute reperfusion minutes group III reperfusion coronary sinus blood flow alpha coronary sinus blood myocardial oxygen consumption reperfusion result groups II III global ventricular function developed pressure maximum dP/dt diastolic compliance control group prostaglandin analog group Myocardial oxygen consumption reperfusion minute group II control group alpha flux group II groups reperfusion results prostaglandin analog beneficial effect myocardial protection global ischemia cardioplegia component cardioplegic solution reperfusion mechanism cytoprotective effect protection endothelium enhanced endogenous prostacyclin production reperfusion modulation reperfusion se 